Long-term l-NAME treatment potentiates the blood-brain barrier disruption during pentylenetetrazole-induced seizures in rats

Life Sciences

Volumn 79, Issue 1, 2006, Pages 16-20

  Kalayci, Rivaze ^a   Kaya, Mehmet ^b   Ahishali, Bulent ^b   Arican, Nadir ^b   Elmas, Imdat ^a,b   Kucuk, Mutlu ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Blood brain barrier; Epileptic seizures; Evans blue; l NAME

Indexed keywords

EVANS BLUE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PENTETRAZOLE; CONVULSANT AGENT; ENZYME INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CORTEX; BRAIN INJURY; CEREBELLUM; CONTROLLED STUDY; DIENCEPHALON; DISEASE EXACERBATION; DRUG EFFECT; ENZYME INHIBITION; EVOKED RESPONSE; HYPERTENSION; LONG TERM CARE; MALE; MORTALITY; NEUROTOXICITY; NONHUMAN; RAT; SEIZURE; SYSTOLIC BLOOD PRESSURE; ANIMAL; BLOOD PRESSURE; CHEMICALLY INDUCED DISORDER; DRUG POTENTIATION; METABOLISM; WISTAR RAT;

ANIMALIA;

ANIMALS; BLOOD PRESSURE; BLOOD-BRAIN BARRIER; CONVULSANTS; DRUG SYNERGISM; ENZYME INHIBITORS; EVANS BLUE; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; PENTYLENETETRAZOLE; RATS; RATS, WISTAR; SEIZURES;

EID: 33745305219     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2005.12.034     Document Type: Article

References (38)

1. Ahishali B., Kaya M., Kalayci R., Uzun H., Bilgic B., Arican N., Elmas I., Aydi{dotless}n S., and Kucuk M. Effects of lipopolysaccharide on the blood-brain barrier permeability in prolonged nitric oxide blockade-induced hypertensive rats. International Journal of Neuroscience 115 2 (2005) 151-168
2. Baylis C., Mitruka B., and Deng A. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. Journal of Clinical Investigation 90 1 (1992) 278-281
3. Blot S., Arnal J.F., Xu Y., Gray F., and Michel J.B. Spinal cord infarcts during long-term inhibition of nitric oxide synthase in rats. Stroke 25 8 (1994) 1666-1673
4. Bolwig T.G. Epileptic seizures and the blood-brain barrier. In: Neuwelt E.A. (Ed). Implications of the Blood-Brain Barrier and its Manipulation (1989), Plenum Medical Book Company, New York 567-574
5. Brierley J.B., Meldrum B.S., and Brown A.W. The threshold and neuropathology of cerebral "anoxic-ischemic" cell change. Archives of Neurology 29 6 (1973) 367-374
6. Cornford E.M., Nguyen E.V., and Landaw E.M. Acute upregulation of blood-brain barrier glucose transporter activity in seizures. American Journal of Physiology. Heart and Circulatory Physiology 279 3 (2000) H1346-H1354
7. De Vasconcelos A.P., Baldwin R.A., and Wasterlain C.G. Nitric oxide mediates the increase in local cerebral blood flow during focal seizures. Proceedings of the National Academy of Sciences of the United States of America 92 8 (1995) 3175-3179
8. Ferraro G., Montalbano M.E., and La Grutta V. Nitric oxide and glutamate interaction in the control of cortical and hippocampal excitability. Epilepsia 40 7 (1999) 830-836
9. Gabriel C., Friguls B., Sureda F.X., Pallas M., Planas A.M., Escubedo E., Camarasa J., and Camins A. Inhibitors of NO-synthase and donors of NO modulate kainic acid-induced damage in the rat hippocampus. Journal of Neuroscience Research 59 6 (2000) 797-805
10. Gonzalez W., Fontaine V., Pueyo M.E., Laquay N., Messika-Zeitoun D., Philippe M., Arnal J.F., Jacob M.P., and Michel J.B. Molecular plasticity of vascular wall during N-omega-nitro-l-arginine methyl ester-induced hypertension. Modulation of proinflammatory signals. Hypertension 36 1 (2000) 103-109
11. Hashizume K., Tanaka T., and Yonemasu Y. Change in cerebral glucose metabolism during limbic seizures elicited from lateral septal nucleus. Epilepsy Research 30 3 (1998) 167-176
12. Jansson A., Mazel T., Andbjer B., Rosen L., Guidolin D., Zoli M., Sykova E., Agnati L.F., and Fuxe K. Effects of nitric oxide inhibition on the spread of biotinylated dextran and on extracellular space parameters in the neostriatum of the male rat. Neuroscience 91 1 (1999) 69-80
13. Kalayci R., Kaya M., Kucuk M., Çimen V., Arican N., Gurses C., and Elmas I. Catalase and alpha-tocopherol attenuate blood-brain barrier breakdown in pentylenetetrazole-induced epileptic seizures in acute hyperglycemic rats. Pharmacological Research 45 2 (2002) 129-133
14. Kalayci R., Kaya M., Elmas I., Arican N., Ahishali B., Uzun H., Bilgic B., Kucuk M., and Kudat H. Effects of atorvastatin on blood-brain barrier permeability during l-NAME hypertension followed by angiotensin-II in rats. Brain Research 1042 2 (2005) 184-193
15. Kaya M., Kucuk M., Kalayci R.B., and Palanduz S. Acute hyperglycemia augments blood-brain barrier damage in experimental status epilepticus. Neuroscience Research Communications 25 2 (1999) 111-119
16. Kucuk M., Kaya M., Kalayci R., Cimen V., Kudat H., Arican N., Elmas I., and Korkut F. Effects of losartan on the blood-brain barrier permeability in long-term nitric oxide blockade-induced hypertensive rats. Life Sciences 71 8 (2002) 937-946
17. Maggio R., Fumagalli F., Donati E., Barbier P., Racagni G., Corsini G.U., and Riva M. Inhibition of nitric oxide synthase dramatically potentiates seizures induced by kainic acid and pilocarpine in rats. Brain Research 679 1 (1995) 184-187
18. Mayhan W.G. Inhibition of nitric oxide synthase does not alter basal permeability of the blood-brain barrier. Brain Research 855 1 (2000) 143-149
19. Meldrum B.S., and Nilssoni B. Cerebral blood flow and metabolic rate early and late in prolonged epileptic seizures induced in rats by bicuculline. Brain 99 3 (1976) 523-542
20. Moncada S., and Higgs A. The l-arginine-nitric oxide pathway. New England Journal of Medicine 329 27 (1993) 2002-2012
21. Nidhi G., Balakrishnan S., and Pandhi P. Role of nitric oxide in electroshock and pentylenetetrazole seizure threshold in rats. Methods and Findings in Experimental and Clinical Pharmacology 21 9 (1999) 609-612
22. Nitsch C., and Klatzo I. Regional patterns of blood-brain barrier breakdown during epileptiform seizures induced by various convulsive agents. Journal of the Neurological Sciences 59 3 (1983) 305-322
23. Penix L.P., Davis W., and Subramaniam S. Inhibition of NO synthase increases the severity of kainic acid-induced seizures in rodents. Epilepsy Research 18 3 (1994) 177-184
24. Prado R., Watson B.D., Kuluz J., and Dietrich W.D. Endothelium-derived nitric oxide synthase inhibition-Effects on cerebral blood flow, pial artery diameter, and vascular morphology in rats. Stroke 23 8 (1992) 1118-1124
25. Rigaud-Monnet A.S., Pinard E., Borredon J., and Seylaz J. Blockade of nitric oxide synthesis inhibits hippocampal hyperemia in kainic acid-induced seizures. Journal of Cerebral Blood Flow and Metabolism 14 4 (1994) 581-590
26. Rigaud-Monnet A.S., Heron A., Seylaz J., and Pinard E. Effect of inhibiting NO synthesis on hippocampal extracellular glutamate concentration in seizures induced by kainic acid. Brain Research 673 2 (1995) 297-303
27. Rondouin G., Bockaert J., and Lerner-Natoli M. l-nitroarginine, an inhibitor of NO synthase, dramatically worsens limbic epilepsy in rats. NeuroReport 4 10 (1993) 1187-1190
28. Rundfeldt C., Koch R., Richter A., Mevissen M., Gerecke U., and Loscher W. Dose-dependent anticonvulsant and proconvulsant effects of nitric oxide synthase inhibitors on seizure threshold in a cortical stimulation model in rats. European Journal of Pharmacology 274 1-3 (1995) 73-81
29. Sharma H.S., and Alm P. Role of nitric oxide on the blood-brain and spinal cord barriers. In: Sharma H.S., and Westman J. (Eds). Blood-Spinal Cord and Brain Barriers in Health and Disease (2004), Elsevier, Sen Diego 191-229
30. Shyamaladevi N., Jayakumar A.R., Sujatha R., Paul V., and Subramanian E.H. Evidence that nitric oxide production increases gamma-amino butyric acid permeability of blood-brain barrier. Brain Research Bulletin 57 2 (2002) 231-236
31. Starr M.S., and Starr B.S. Paradoxical facilitation of pilocarpine-induced seizures in the mouse by MK-801 and the nitric oxide synthesis inhibitor l-NAME. Pharmacology, Biochemistry, and Behavior 45 2 (1993) 321-325
32. Suda O., Tsutsui M., Morishita T., Tanimoto A., Horiuchi M., Tasaki H., Huang P.L., Sasaguri Y., Yanagihara N., and Nakashima Y. Long-term treatment with N(omega)-nitro-l-arginine methyl ester causes arteriosclerotic coronary lesions in endothelial nitric oxide synthase-deficient mice. Circulation 106 13 (2002) 1729-1735
33. Suzuki R., Nitsch C., Fujiwara K., and Klatzo I. Regional changes in cerebral blood flow and blood-brain barrier permeability during epileptiform seizures and in acute hypertension in rabbits. Journal of Cerebral Blood Flow and Metabolism 4 1 (1984) 96-102
34. Tsuda M., Suzuki T., and Misawa M. Aggravation of DMCM-induced seizure by nitric oxide synthase inhibitors in mice. Life Sciences 60 23 (1997) PL339-PL343
35. Tutka P., Mlynarczyk M., Zolkowska D., and Kleinrok Z. NG-nitro-l-arginine sensitizes mice to 4-aminopyridine-induced seizures. Acta Physiologica Hungarica 84 4 (1996) 471-472
36. Wink D.A., Hanbauer I., Krishna M.C., DeGraff W., Gamson J., and Mitchell J.B. Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species. Proceedings of the National Academy of Sciences of the United States of America 90 21 (1993) 9813-9817
37. van Eijsden P., Notenboom R.G., Wu O., de Graan P.N., van Nieuwenhuizen O., Nicolay K., and Braun K.P. In vivo 1H magnetic resonance spectroscopy, T2-weighted and diffusion-weighted MRI during lithium-pilocarpine-induced status epilepticus in the rat. Brain Research 1030 1 (2004) 11-18
38. Zhao Q., Egashira K., Inoue S., Usui M., Kitamoto S., Ni W., Ishibashi M., Hiasa K., Ichiki T., Shibuya M., and Takeshita A. Vascular endothelial growth factor is necessary in the development of arteriosclerosis by recruiting/activating monocytes in a rat model of long-term inhibition of nitric oxide synthesis. Circulation 105 9 (2002) 1110-1115